In silico dose prediction for long-acting rilpivirine and cabotegravir administration to children and adolescents

類似資料

• Physiologically-Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long Acting Nanoformulations for HIV
  著者:: Rajoli, Rajith KR, 等
  出版事項: (2015)
• Predicting Drug–Drug Interactions Between Rifampicin and Long-Acting Cabotegravir and Rilpivirine Using Physiologically Based Pharmacokinetic Modeling
  著者:: Rajoli, Rajith K R, 等
  出版事項: (2019)
• Modeling the long-acting administration of anti-tuberculosis agents using PBPK – a proof of concept study
  著者:: Rajoli, Rajith KR, 等
  出版事項: (2018)
• Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine
  著者:: Hodge, Daryl, 等
  出版事項: (2021)
• Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapies
  著者:: Hobson, James J., 等
  出版事項: (2019)